Manipal Health IPO Review: Should Investors Apply For Long-Term Growth Or Avoid It?

Manipal Health IPO Review: Should Investors Apply For Long-Term Growth Or Avoid It?

Advertisement
Sakshi Batra
  • Updated Jul 29, 2026 1:38 PM IST

 

Manipal Health IPO has opened for subscription, attracting investor attention as one of India's largest healthcare offerings. The IPO aims to raise around ₹9,275 crore, with a strong brand presence, over 13,000 beds, and expansion plans across key markets. Thomas V. Abraham, Research Analyst, Mirae Asset Sharekhan, believes the hospital sector has strong long-term growth potential, supported by rising healthcare demand and insurance penetration. While valuations appear in line with peers, concerns around pricing, debt reduction, geographic concentration, and listing gains remain. Investors must evaluate the IPO from a long-term perspective rather than short-term listing returns.

Advertisement